FDA's Regulation of Gentian Violet Appears Reasonable
HRD-80-91: Published: Aug 14, 1980. Publicly Released: Aug 27, 1980.
Additional Materials:
- Full Report:
Contact:
Gentian violet, a dye, has been used as an animal drug to treat many diseases and as an additive in animal feed to inhibit mold. When drugs are to be used in food-producing animals, the Food and Drug Administration (FDA) must approve the safety of any residues in food. FDA actions in regulating gentian violet have been questioned. GAO was asked to determine whether some FDA officials exhibited malice against certain companies and individuals; the FDA regulatory machinery was improperly used to force some companies out of the market; and FDA was unresponsive to efforts made in good faith by three companies to resolve problems concerning the adequacy of safety and effectiveness data they submitted to FDA.
No evidence was found to substantiate any of the charges. FDA has not approved gentian violet for use in veterinary products and has determined that gentian violet does not qualify for interim food additive status. The safety and effectiveness of gentian violet in veterinary use have not not been demonstrated, nor has its effectiveness as a mold inhibitor in animal feeds been demonstrated. According to FDA, the safety must be demonstrated in long-term tests designed to assess whether or not gentian violet is carcinogenic. The GAO review disclosed that the regulatory actions taken by FDA against three firms were not unreasonable in view of the FDA decisions that gentian violet products are unapproved as food additives and new animal drugs. In nine out of ten cases, FDA action has been upheld by the courts. One firm reviewed, Naremco, alleged that certain actions taken by FDA were unreasonable, overstepped agency authority, or deliberately attempted to discredit or drive the firm out of business. Although some statements made by FDA officials to Members of Congress were inaccurate, GAO could not conclude that these were deliberate attempts to discredit or drive the firm out of business. Officials of the other two firms reviewed believed that failure to gain approval for their products was a result of the FDA dealings with Naremco and that the FDA refusal to permit them to market gentian violet products was the result of the FDA desire to restrict Naremco from selling such products.
Oct 26, 2020
-
Intellectual Property:
CBP Has Taken Steps to Combat Counterfeit Goods in Small Packages but Could Streamline EnforcementGAO-20-692: Published: Sep 24, 2020. Publicly Released: Oct 26, 2020.
Sep 30, 2020
-
Federal Criminal Restitution:
Department of Justice Has Ongoing Efforts to Improve Its Oversight of the Collection of Restitution and Tracking the Use of Forfeited AssetsGAO-20-676R: Published: Sep 30, 2020. Publicly Released: Sep 30, 2020.
Sep 10, 2020
-
Federal Tactical Teams:
Characteristics, Training, Deployments, and InventoryGAO-20-710: Published: Sep 10, 2020. Publicly Released: Sep 10, 2020.
Sep 8, 2020
-
VA Police:
Actions Needed to Improve Data Completeness and Accuracy on Use of Force Incidents at Medical CentersGAO-20-599: Published: Sep 8, 2020. Publicly Released: Sep 8, 2020.
Aug 13, 2020
-
Anti-Money Laundering:
FinCEN Should Enhance Procedures for Implementing and Evaluating Geographic Targeting OrdersGAO-20-546: Published: Jul 14, 2020. Publicly Released: Aug 13, 2020.
Jul 29, 2020
-
Federal Prison Industries:
Actions Needed to Evaluate Program EffectivenessGAO-20-505: Published: Jul 29, 2020. Publicly Released: Jul 29, 2020.
Jul 8, 2020
-
Gun Control:
DOJ Can Further Improve Guidance on Federal Firearm Background Check RecordsGAO-20-528: Published: Jul 8, 2020. Publicly Released: Jul 8, 2020.
Jun 22, 2020
-
Federal Prisons:
Additional Analysis Needed to Determine Whether to Issue Pepper Spray to Minimum Security PrisonsGAO-20-342: Published: Jun 22, 2020. Publicly Released: Jun 22, 2020.
May 26, 2020
-
Bureau of Prisons:
Improved Planning Would Help BOP Evaluate and Manage Its Portfolio of Drug Education and Treatment ProgramsGAO-20-423: Published: May 26, 2020. Publicly Released: May 26, 2020.
May 12, 2020
-
Forensic Technology:
Algorithms Used in Federal Law EnforcementGAO-20-479SP: Published: May 12, 2020. Publicly Released: May 12, 2020.
Looking for more? Browse all our products here